Personalized oncology with artificial intelligence: The case of temozolomide

Nicolas Houy () and François Le Grand
Additional contact information
Nicolas Houy: GATE Lyon Saint-Étienne - Groupe d'Analyse et de Théorie Economique Lyon - Saint-Etienne - ENS de Lyon - École normale supérieure de Lyon - Université de Lyon - UL2 - Université Lumière - Lyon 2 - UCBL - Université Claude Bernard Lyon 1 - Université de Lyon - UJM - Université Jean Monnet - Saint-Étienne - CNRS - Centre National de la Recherche Scientifique
François Le Grand: EM - EMLyon Business School

Post-Print from HAL

Date: 2019-08
Note: View the original document on HAL open archive server: https://shs.hal.science/halshs-02386458v1
References: View references in EconPapers View complete reference list from CitEc
Citations:

Published in Artificial Intelligence in Medicine, 2019, 99, pp.101693. ⟨10.1016/j.artmed.2019.07.001⟩

Downloads: (external link)
https://shs.hal.science/halshs-02386458v1/document (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-02386458

DOI: 10.1016/j.artmed.2019.07.001

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().